alexa TRA-1-60+, SSEA-4+, Oct4A+, Nanog+ Clones of Pluripotent Stem Cells in the Embryonal Carcinomas of the Ovaries | OMICS International | Abstract
ISSN: 2157-7633

Journal of Stem Cell Research & Therapy
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

TRA-1-60+, SSEA-4+, Oct4A+, Nanog+ Clones of Pluripotent Stem Cells in the Embryonal Carcinomas of the Ovaries

Marek Maleckia,b,*, Mark Andersona,c, Michael Beauchained, Songwon Seoa, Xenia Tombokane and Raf Maleckif

aUniversity of Wisconsin, Madison, WI, USA

bPhoenix Biomolecular Engineering Foundation, San Francisco, CA, USA

cNational Institutes of Health, National Nuclear Magnetic Resonance Facility, Madison, WI, USA

dBruker AXS, Fitchburg, WI, USA

eBruker Optics, Dallas, TX, USA

fSan Francisco State University, San Francisco, CA, USA

*Corresponding Author:
Marek Malecki, MD, PhD, UW
Madison, WI and PBMEF, San Francisco, CA, USA
Tel: 4157134370
E-Mail: [email protected]

Received date October 08, 2012; Accepted date November 15, 2012; Published date November 18, 2012

Citation: Malecki M, Anderson M, Beauchaine M, Seo S, Tombokan X, et al. (2012) TRA-1-60+, SSEA-4+, Oct4A+, Nanog+ Clones of Pluripotent Stem Cells in Embryonal Carcinomas of the Ovaries. J Stem Cell Research and Therapy. 2:130. doi:10.4172/2157-7633.1000130

Copyright: © 2012 Malecki M, et al. This is an open-access article distributed underthe terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Introduction:
Embryonal Carcinoma of the Ovary (ECO), pure or admixed to other tumors, is the deadly gynecological cancer.
Specific aim: The specific aim of this work was identification, isolation, clonal expansion, and molecular profiling of the pluripotent cells in the embryonal carcinomas of the ovaries.
Patients and methods: The samples were collected from the patients, who were clinically and histopathologically diagnosed with the advanced, pure ECO. Preparation of the samples was initiated by negative selection of the cells by MACS, while using the superparamagnetic scFvs against phosphatidylserine (PS), and dsDNA, CD45, CD34, CD19, CD14, and by positive selection, while using the superparamagnetic scFvs for TRA-1-60 and SSEA-4. The cell surface display was analyzed by flow cytometry (FCM), immunoblotting (IB), multiphoton fluorescence spectroscopy (MPFS), nuclear magnetic resonance spectroscopy (NMRS), and total reflection x-ray spectroscopy (TRXFS). The transcripts of the OCT4A and Nanog were analyzed by qRTPCR and MPFS. The human pluripotent, embryonic stem cells (ESC), human pluripotent, embryonal carcinoma of the testes (ECT), healthy tissues of the ovary (HTO), healthy tissue of the testes, peripheral blood mononuclear cells (PBMC), and bone marrow mononuclear cells (BMMC) served as the controls.
Results: The studied embryonal carcinomas of the ovary (ECO) contained the cells with significantly higher intensity of the surface display of the TRA-1-60 and SSEA-4, relative to the BMMC, PBMC, and HTO, but similar to the pluripotent ESC and ECT. Their morphology and ultrastructure were consistent with the histopathological diagnoses. Moreover, these cells were significantly stronger expressers of the Oct4A and Nanog, relative to the PBMC, BMMC, and HTO, but similar relative to the pluripotent ESC and ECT. The ECO cells formed embryoid bodies, which differentiated into ectoderm, mesoderm, and endoderm. These cells were induced to differentiate into muscles, epithelia, and neurons.
Conclusion: Herein, we revealed presence and identify molecular profiles of the clones of the pluripotent stem cells in the embryonal carcinomas of the ovaries. These results should help us with refining molecular diagnoses of these deadly neoplasms.

Keywords

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri and Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

streamtajm

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7